A detailed history of Canada Pension Plan Investment Board transactions in Repligen Corp stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 5,500 shares of RGEN stock, worth $808,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,500
Holding current value
$808,059
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$123.41 - $160.92 $678,755 - $885,059
5,500 New
5,500 $791,000
Q2 2024

Aug 12, 2024

BUY
$120.0 - $182.95 $156,000 - $237,834
1,300 New
1,300 $163,000
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $176,462 - $281,831
-1,100 Reduced 70.24%
466 $87,000
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $50.3 Million - $67.3 Million
-357,800 Reduced 99.56%
1,566 $254,000
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $250,972 - $401,643
1,557 Added 0.44%
359,366 $67.6 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $50,013 - $61,502
-202 Reduced 0.06%
357,809 $94.8 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $66,611 - $110,879
-342 Reduced 0.1%
358,011 $103 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $291,765 - $388,651
-1,759 Reduced 0.49%
358,353 $71.5 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $137,441 - $172,410
762 Added 0.21%
360,112 $70 Million
Q4 2020

Feb 17, 2021

BUY
$148.08 - $206.57 $196,798 - $274,531
1,329 Added 0.37%
359,350 $68.9 Million
Q3 2020

Nov 12, 2020

SELL
$122.51 - $158.27 $254,698 - $329,043
-2,079 Reduced 0.58%
358,021 $52.8 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $5.67 Million - $8.44 Million
60,100 Added 20.03%
360,100 $44.5 Million
Q1 2020

May 13, 2020

BUY
$84.96 - $109.14 $25.5 Million - $32.7 Million
299,747 Added 118477.08%
300,000 $29 Million
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $18,681 - $23,549
253 New
253 $23,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.